Mark Anthony McCamish, Director at AVADEL PHARMACEUTICALS PLC (AVDL), sold 57,950 shares at $14.93 ($865K) on 2023-08-11, disclosed to the SEC on 2023-08-15.
Open-market sale of $865k AVDL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.93 | 28,975 | $433K | 50.0% |
| 2 | $14.93 | 28,975 | $433K | 50.0% |
| Total | $14.93 avg | 57,950 | $865K | 100% |
| Filing → |
| FTSV | SELL | 2020-04-03 | $6.2M | — | Filing → |
| FTSV | SELL | 2019-06-27 | $181K | — | Filing → |
| FTSV | SELL | 2019-06-24 | $183K | — | Filing → |